Twin Securities’s Terns Pharmaceuticals TERN Stock Holding History

Twin Securities’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-115,958	Closed	-$6.11M	–	23
2026 Q1	$6.11M	Buy	+115,958	New	+$4.76M	2.97%	7

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Twin Securities's TERN Position: Q2 2026 in Review

Twin Securities sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 115,958 shares — an estimated $6.11M sold.

Twin Securities first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $6.11M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Twin Securities reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Twin Securities sold 115,958 Terns Pharmaceuticals shares in Q2 2026, an estimated $6.11M.
Twin Securities first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Twin Securities's Terns Pharmaceuticals position peaked at $6.11M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Twin Securities's 13F filing for Q2 2026, filed 14 Aug 2026.